Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era

Introduction Primary liver cancer is a major health problem being the sixth most frequent cancer in the world and the third cause of cancer-related death in the world. The most common histological type of liver cancer is hepatocellular carcinoma (HCC, 75–80%).